Results 91 to 100 of about 28,228 (226)

Losartan: a pharmacoeconomic review

Journal of Medical Economics, 2007
SummaryThe angiotensin II antagonist losartan has been clinically studied in several patient populations including type 2 diabetes mellitus (T2DM) with nephropathy, hypertension with left ventricular hypertrophy, and the elderly with heart failure. The aim of this paper is to provide a review of the health economic evaluations based on the clinical ...
openaire   +2 more sources

Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II [PDF]

, 1999
Judith Miller, Kerri Thai, James W. Scholey   +2 more
openalex   +1 more source

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats

Journal of Applied Oral Science
Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats.
Gabriel Mulinari-Santos, Jaqueline Silva dos Santos, Letícia Pitol Palin, Ana Cláudia Ervolino da Silva, Cristina Antoniali, Leonardo Perez Faverani, Roberta Okamoto   +6 more
doaj   +1 more source

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients [PDF]

, 1998
R. Fogari, Annalisa Zoppi, Luca Corradi, Pierangelo Lazzari, Amedeo Mugellini, Paola Lusardi   +5 more
openalex   +1 more source

Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen‐2)27), hypertensive rats [PDF]

, 1995
Sheila M. Gardiner, J E March, P.A. Kemp, John J. Mullins, T. Bennett   +4 more
openalex   +1 more source

Candesartan vs losartan [PDF]

Journal of Human Hypertension, 1998
A Dumaswala, T Bunt
openaire   +2 more sources

Spectrophotometric Determination of Losartan Potassium in Tablets

Science Diliman, 2014
In the quality control of pharmaceutical products, it is of utmost importance that validated analytical methods are used to ensure the credibility of the results generated. At the time of the study, official monographs from the United States Pharmacopeia
Arianne Diane A. Aniñon, Richard Simon R. Binos, Karen Mae M. Brizuela, Willison John C. de Luna, Regine Philline S. del Rosario, Jesus John C. Dimalala, Timothy Joseph P. Dueñas, Isaac Ireneo B. Linatoc, Juan Paolo D. Recto, Melanie V. Salinas, West Kristian D. Paraiso   +10 more
doaj  

Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan

, 1994
H Ji, Mandy H. M. Leung, Yong Zhang, Kevin Catt, Kathryn Sandberg   +4 more
openalex   +1 more source

Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren‐2 transgenic rats [PDF]

, 1997
Concepción Peiró, José L Llergo, Javier Angulo, José M. López‐Novoa, Ana M. Rodrı́guez-López, Leocadio Rodríguez‐Mañas, Carlos F. Sánchez‐Ferrer   +6 more
openalex   +1 more source

Effects of Losartan on Capillary Density in Cardiac Muscles of Diabetic Rats

مجله دانشکده پزشکی اصفهان, 2012
Background: Stimulatory and/or inhibitory effects of angiotensin II is attributed to angiotensin receptor I. A few studies investigated the role of angiotensin receptor I on cardiovascular system in diabetic subjects.
Ali Reza Fallahzadeh, Noushin Afsharmoghaddam, Majid Khazaei   +2 more
doaj